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Ethical Issues in
Human Subjects Research

Martha Jones, MA, CIP
Sarah Fowler-Dixon, PhD, CIP

Some Basics
• What is research?
• What is beneficence?
– What are some potential benefits?
– What types of risks may exist?
– How are risks assessed?

• How is consent handled with minors?

Think about
• Is it research?
– Applicable federal, state and local
regulations

• Foreseeable risks and potential
benefits
– Are risks reasonable given the potential
benefits?
– Are there some risks that are so
objectionable that they should never be
authorized regardless of the benefits?
– Physical, Psychological, Social, Economic
and Legal risks

Think about
• Consent and Assent processes
– What is the relationship between risk
assessment and informed consent?
• If the participants are informed does that make the
risks acceptable?

– Most appropriate consent/assent for the study
• Should potential participants be engaged in a
discussion?

• Maintaining participant privacy and data
confidentiality
• Protections for vulnerable populations

Case Example 1
• A researcher wants to conduct a chart
review of patients from 1999 to 2006.
This researcher is interested in
collecting height, weight, amount of
blood drawn and reason for blood
draw. The researcher hopes to
establish standard practices and
based on results may want to continue
the study to affect change in standard
practices.
– Is this research?

Case Example 2
• A child has been treated unsuccessfully
over the years and has finally decided
that he does not want any more
treatment.
– What should happen if the parents want to
enroll the child in a protocol examining a
promising new treatment that might benefit
the child, but the child is unwilling to
assent?
– Is there a therapeutic misconception in
play?

Case Example 3
• A study wants to conduct allergy skin
testing on children. There is no direct
benefit to the children enrolled in this
study. The children being enrolled are
considered “healthy, with no known
allergies.”
– When do you transition from minimal risk
to greater than minimal risk?
– Would one or two parent signatures be
required?

Risk Ratings for Minors
• 46.404; 50.51: Minimal Risk means
that the probability and magnitude of
harm or discomfort anticipated in the
research are not greater in and of
themselves than those ordinarily
encountered in daily life or during the
performance of routine physical or
psychological examinations or tests.
– One parent signature

46.405
• 46.405; 50.52: The research risk is
greater than minimal and it presents the
prospect of direct benefit to the
participant.
– One parent signature

46.406
• 46.406; 50.53: The research is greater than minimal
risk with no direct benefit to the minors but it is likely
to yield generalizable knowledge about the subject’s
disorder or condition. And/or, the minors being
recruited have a disorder or condition that would
place them in a group other than average healthy
child therefore, the research is a minor increment
over minimal risk. (This risk is slightly more than
what the average healthy minor would experience but
is an experience or an expectation given their
condition.)
– Two parent signatures

407
• 46.407; 50.54: The research uses minors
that do not have the disease being studied
and is greater than minimal risk. It presents
an opportunity to understand, prevent, or
alleviate a serious problem affecting the
health and welfare of minors but presents no
direct benefits to the participants. (Please
note, research in this category must be
reviewed by the HRPO and then submitted to
the DHHS Secretary for review by a panel of
experts.)
– Two parent signatures

Reference Material
Found at http://hrpohome.wustl.edu.
• 45 CFR 46, subpart D children
• 45 CFR 46.404, 46.405, 46.406, 46.407
• 21 CFR 50.51, 50.52, 50.53, 50.54
• WU Assent Guideline,
• WU Consent Guideline
• WU Wards of State Guideline

Reference Material
• THE ETHICS AND REGULATION OF
RESEARCH WITH HUMAN SUBJECTS BY
CARL H. COLEMAN, JERRY A. MENIKOFF,
JESSE A. GOLDNER, AND NANCY
NEVELOFF DUBLER PUBLISHED BY LEXIS
NEXIS

Bonus Case Example
• A researcher is interested in studying
contraceptive choices amongst adolescents. As
adolescents present to Planned Parenthood, they
will be given a questionnaire about current
contraceptive choices and information about
contraceptives available. The idea is to not only
gather information about current beliefs and
choices but also educate adolescents about
choices.
–
–
–
–

Can the minors consent for themselves?
What about privacy and confidentiality?
What are the risks?
What happens if a minor turns out to be a Ward of
the State? Does this change matters? How?

